EQL Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 24 May 24 | BuySEK 2,536,136 | Axel Schorling | Individual | 53,903 | SEK 47.05 | |
| 24 May 24 | BuySEK 2,536,136 | Axel Schorling | Individual | 53,903 | SEK 47.05 | |
| 12 Dec 23 | SellSEK 9,900,002 | FÅRö Capital Ab | Company | 300,000 | SEK 33.00 |
Insider Trading Volume
Insider Buying: EQL insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 2,046,012 | 7.04% |
| Institutions | 2,702,554 | 9.3% |
| General Public | 7,469,196 | 25.7% |
| VC/PE Firms | 8,127,348 | 28% |
| Private Companies | 8,718,500 | 30% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 8,718,500 | SEK 500.4m | 0% | no data | |||
| 8,127,348 | SEK 466.5m | 0% | 97.36% | |||
| 956,193 | SEK 54.9m | 0% | 0.12% | |||
| 636,493 | SEK 36.5m | 0% | 0.01% | |||
| 447,580 | SEK 25.7m | 0% | no data | |||
| 360,389 | SEK 20.7m | 0% | no data | |||
| 345,857 | SEK 19.9m | 0% | 0.03% | |||
| 319,700 | SEK 18.4m | 0% | no data | |||
| 311,016 | SEK 17.9m | 21% | no data | |||
| 308,074 | SEK 17.7m | 0% | 0.05% | |||
| 299,355 | SEK 17.2m | 0% | no data | |||
| 256,543 | SEK 14.7m | 0% | no data | |||
| 250,000 | SEK 14.3m | 0% | no data | |||
| 205,937 | SEK 11.8m | 302% | no data | |||
| 15,200 | SEK 872.5k | 0% | no data | |||
| 13,729 | SEK 788.1k | 0% | no data | |||
| 10,000 | SEK 574.0k | 0% | no data | |||
| 10,000 | SEK 574.0k | 0% | no data | |||
| 2,500 | SEK 143.5k | 0% | no data |